Table 3.
Hospitalization characteristics of patients admitted through Level IV (Landstuhl Regional Medical Center) (June–August 2009) following traumatic injury
| Trauma patients admitted at Level IV | ||||||
|---|---|---|---|---|---|---|
| Level IV → Level V (TIDOS participating sites) |
||||||
| Characteristic | Level IV → RTD (N=18) |
Level IV →Level V (other sites) (N=144) |
TIDOS enrolled (N=104) |
Not enrolled (N=88) |
||
| Level IV Admission |
Level V Admission |
Level IV Admission |
Level V Admission |
|||
| Days Hospitalized, median (IQR) | 3 (1–10) | 4 (3–6) | 2 (1–3) | 16 (6–45) | 2 (1–4) | 10 (3–21) |
| ICU admission (%)1 | 4 (22.2) | 25 (16.8) | 46 (44.2) | 37 (41.6) | 48 (57.1) | 20 (37.0) |
| Days in ICU, median (IQR) | 2 (1–3) | 2 (1–3) | 2 (1–3) | 3 (4–6) | 2 (1–4) | 3 (2–11) |
| Mechanical ventilation (%)1 | 0 (0) | 10 (6.7) | 26 (25.0) | 9 (10.1) | 30 (35.7) | 7 (13.0) |
| Days on Ventilator, median (IQR) | - | 1 (1–4) | 1 (1–2) | 2 (2–3) | 2 (1–3) | 7 (5–13) |
| Median number operating room visits/week (IQR) | 1(1–2) | 1(1-1) | 1 (1-1) | 3(2–7) | 1(1-1) | 2.5(1–4) |
| Level III/IV - 24 h blood transfusion ≥ 10 units (%)1 | 0 (0.0) | 1 (0.7) | 7 (6.9) | - | 9 (10.3) | - |
| Admission SOFA2 – Mean (std dev) | 0.56(1.10) | 0.76(2.0) | 2.45 (3.18) | 0.98(2.04) | 2.67(3.19) | 1.46(2.75) |
| Abnormal SOFA score component (%) | ||||||
| Respiration (PaO2/FiO2 < 400) | 1 (5.6) | 4 (2.7) | 14 (13.5) | 6 (5.8) | 10 (11.4) | 13 (14.8) |
| Coagulation (platelets < 150 103/mm3) | 2 (11.1) | 15 (10.3) | 50 (48.1) | 20 (19.2) | 41 (46.6) | 15 (17.0) |
| Hepatic Function (bilirubin > 1.2mg/dl) | 1 (5.6) | 21 (14.4) | 27 (26.0) | 11 (10.6) | 25 (28.4) | 11 (12.5) |
| Cardiovascular (mean arterial pressure < 70 mmHg) | 2 (11.1) | 23 (15.8) | 17 (16.3) | 10 (9.6) | 8 (9.1) | 4 (4.5) |
| Neurological Function (Glascow coma scale < 15) | 1 (5.6) | 7 (4.8) | 30 (28.8) | 11 (10.6) | 31 (35.2) | 17 (19.3) |
| Renal Function (creatinine > 1.2 mg/dl) | 1 (5.6) | 11 (7.5) | 8 (7.7) | 2 (1.9) | 12 (13.6) | 3 (3.4) |
| Clinical course/intervention (%) | ||||||
| Central line | 3 (16.7) | 8 (5.6) | 34 (32.7) | 33 (31.7) | 33 (37.5) | 30 (34.1) |
| Enteric feeding tube | 0 | 0 | 13 (12.5) | 11 (10.6) | 17 (19.3) | 17 (19.3) |
| Chest tube | 0 | 3 (2.1) | 6 (5.8) | 6 (5.8) | 13 (14.8) | 13 (14.8) |
| Ventriculostomy | 0 | 0 | 0 | 0 | 5 (5.7) | 6 (6.8) |
| Total parenteral nutrition | 0 | 0 | 1 (1.0) | 5 (4.8) | 0 | 3 (3.4) |
| Vasopressor therapy | 0 | 2 (1.4) | 4 (3.8) | 1 (1.0) | 5 (5.7) | 5 (5.7) |
| Discharge Status (%) | ||||||
| Indwelling orthopedic hardware | 6 (33.3) | 19 (13.2) | 23 (22.1) | 50 (48.1) | 16 (18.2) | 30(34.1) |
| Indwelling intravascular line | 2 (11.1) | 12 (8.3) | 22 (21.2) | 13(12.5) | 17 (19.3) | 7 (8.0) |
| Antimicrobial therapy3 | 6 (33.3) | 86 (59.7) | 94 (90.4) | 43 (41.3) | 74 (84.1) | 37(42.0) |
Note: Numbers represent patient numbers with percentages in parentheses unless otherwise indicated.
1
Denominator based on JTTR registrant available data.
2
Sequential Organ Failure Assessment (SOFA)16
3
Antimicrobial therapy does not include anti-malarial prophylaxis post-deployment (i.e. doxycycline, mefloquine, atovaquone/proguanil)